HOME >> BIOLOGY >> NEWS
Preterm infants with RDS -- surfactant replacement therapies improves neonatal survival

Napa, CA and Parma, Italy (May 7, 2007) -- Data presented today at the Pediatric Academic Societies Annual Meeting demonstrate that premature infants with neonatal Respiratory Distress Syndrome (RDS) have a nearly 20% better chance of survival if they are treated with Curosurf (poractant alfa) Intratracheal Suspension rather than either of two competing surfactant therapies. "Differences in Mortality Among Infants Treated with Three Different Natural Surfactants for Respiratory Distress Syndrome (RDS)," a retrospective analysis of a very large database maintained by Premier Inc., considered specific procedures and clinical outcomes for 24,883 premature infants treated for RDS at 191 U.S. hospitals from January 2003 to June 2006. The alternative surfactant therapies over which Curosurf Intratracheal Suspension showed a nearly 20% mortality advantage are Survanta (beractant) and Infasurf (calfactant). Full disclosure of the data are being held pending publication.

Jatinder J. Bhatia, MD, Professor and Chief, Section of Neonatology in the Department of Pediatrics, Medical College of Georgia, commented, "Clinicians have long needed a robust basis upon which to choose surfactant therapies for premature babies suffering form RDS. Even though natural surfactants have appeared for some time to perform better than synthetic ones, and despite the significant differences in mortality that randomized trials have suggested among the three commonly available natural surfactants, there has been no single study comparing the mortality rates of all three natural surfactants."

According to Dr. Bhatia, "The present research analyzes summary data from an extensive administrative database of actual real-world clinical outcomes. The sheer size of the sample as well as the consistency of its results across different hospital settings underscores the validity of the findings. The study controlled for six variables that could have confounded results, and derive
'"/>

Contact: Harriet Ullman
harriet.ullman@fkhealth.com
617-761-6776
Feinstein Kean Healthcare
7-May-2007


Page: 1 2 3

Related biology news :

1. Pregnancy news -- Preterm delivery risk reduced by high-dose progesterone treatment
2. Preterm birth risk quickly and accurately detected with proteomic profiling
3. Prenatal stress keeps infants, toddlers up at night, study says
4. Nearly 28,000 US infants died in 2004
5. Early exposure to indoor fungus molecules may protect infants against future allergies
6. Different approach needed to protect brains of premature infants
7. Mutant gene causes severe kidney disease in infants
8. A cognitive strategy shared by human infants and our great-ape kin
9. Full year of treatment helps infants and children with toxoplasmosis
10. Key nutrients critical for older infants development
11. New observational study suggests use of combination vaccines may improve immunization coverage rates in infants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2018)... (PRWEB) , ... August 07, 2018 , ... CallTower ... today their new CT Cloud Voice and SIP solutions. CT Cloud solutions are ... secure, quality voice solution that is far superior to traditional PBX systems, at a ...
(Date:8/1/2018)... ... August 01, 2018 , ... ... the release of Limfinity® version 7.1. Limfinity® is the software framework that all ... creates new possibilities for both current users and the future of RURO’s laboratory ...
(Date:7/31/2018)... ... July 31, 2018 , ... GSL Biotech has released a new ... the leading cloud-based Electronic Lab Notebook (ELN) platform. , SnapGene specializes in the ... of their research data records in a secure, compliant online platform. Among the ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... CITY, N.Y. (PRWEB) , ... August 08, 2018 , ... ... the healthcare space, today announced that they will be exhibiting at Biotech Week ... , InTouchMD will be showcasing its Pulse platform, healthcare’s most powerful all ...
(Date:8/9/2018)... WALTHAM, MAss. (PRWEB) , ... August 09, 2018 ... ... diverse group of architectural, engineering, and construction (AEC) experts with building owners and ... New England. The fourth-annual Create + Construct symposium comes to Boston for the ...
(Date:7/31/2018)... ... 2018 , ... Leading regenerative veterinary medicine company, VetStem Biopharma, ... adipose tissue-derived stem cells to treat or prevent inflammation at the site of ... specifically, VetStem has been issued similar patents that cover the United States as ...
(Date:7/26/2018)... ... July 26, 2018 , ... ... impact of a biofield energy treated nutraceutical to improve anti-inflammatory and immune function ... response assessed in the preclinical research, were significantly reduced. Results are as follows:, ...
Breaking Biology Technology:
Cached News: